Selection of potential therapeutic bacteriophages that lyse a CTX-M-15 extended spectrum β-lactamase producing Salmonella enterica serovar Typhi strain from the Democratic Republic of the Congo

Elene Kakabadze, Khatuna Makalatia, Nino Grdzelishvili, Nata Bakuradze, Marina Goderdzishvili, Ia Kusradze, Marie-France Phoba, Octavie Lunguya, Cédric Lood, Rob Lavigne, Jan Jacobs, Stijn Deborggraeve, Tessa De Block, Sandra Van Puyvelde, David Lee, Aidan Coffey, Anahit Sedrakyan, Patrick Soentjens, Daniel De Vos, Jean-Paul PirnayNina Chanishvili

Research output: Contribution to journalA2: International peer reviewed article (not A1-type)

Abstract

Recently, aSalmonellaTyphi isolate producing CTX-M-15 extended spectrum β-lactamase (ESBL) and with decreased ciprofloxacin susceptibility was isolated in the Democratic Republic of the Congo. We have selected bacteriophages that show strong lytic activity against this isolate and have potential for phage-based treatment ofS. Typhi, andSalmonellain general.

Original languageEnglish
JournalViruses
Volume10
Issue number4
Pages (from-to)172
Number of pages9
ISSN1999-4915
DOIs
Publication statusPublished - 2018

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Selection of potential therapeutic bacteriophages that lyse a CTX-M-15 extended spectrum β-lactamase producing<em> Salmonella enterica</em> serovar Typhi strain from the Democratic Republic of the Congo'. Together they form a unique fingerprint.

Cite this